Exelixis Q4 Revenues Surge, Losses Sharply Up

genomeweb
360dx

Exelixis Q4 Revenues Surge, Losses Sharply Up

Feb 28, 2001

NEW YORK, Feb 28 - Exelixis reported Wednesday rising revenues for fourth-quarter 2000 and the year Wednesday, amid widening fourth-quarter and year-end losses.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Diagenode Acquires Epigenetics Firm Nxt-Dx
New Products Posted to GenomeWeb: Helomics, Empirical Bioscience, IncellDx, More
Signature Science Wins $2.3M Government Contract to Develop Forensic Tool
Illumina Prices Senior Notes Offering
Canadian Government, Industry Invest C$21M in Genomic Applications Program
CoreBiome Awarded $220K Translational Product Development Grant

The Scan

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

Main menu